Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
47.69
+0.57 (1.21%)
At close: Feb 13, 2026, 4:00 PM EST
47.70
+0.01 (0.02%)
After-hours: Feb 13, 2026, 5:47 PM EST
Harrow Employees
Harrow had 382 employees as of December 31, 2024. The number of employees increased by 67 or 21.27% compared to the previous year.
Employees
382
Change (1Y)
67
Growth (1Y)
21.27%
Revenue / Employee
$654,560
Profits / Employee
-$13,058
Market Cap
1.77B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 382 | 67 | 21.27% | 382 | 0 |
| Dec 31, 2023 | 315 | 98 | 45.16% | 315 | 0 |
| Dec 31, 2022 | 217 | 35 | 19.23% | 217 | 0 |
| Dec 31, 2021 | 182 | 57 | 45.60% | 182 | 0 |
| Dec 31, 2020 | 125 | -8 | -6.02% | 125 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,700 |
| Perrigo Company | 8,379 |
| Evotec SE | 4,788 |
| Phibro Animal Health | 2,475 |
| Amphastar Pharmaceuticals | 2,028 |
| Alvotech | 1,012 |
| ANI Pharmaceuticals | 897 |
| BioCryst Pharmaceuticals | 580 |
HROW News
- 11 days ago - Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth - GlobeNewsWire
- 22 days ago - Harrow: Revisiting This Eyecare Growth Story Ahead Of Q4 Update - Seeking Alpha
- 4 weeks ago - Harrow: Flirting With Missing 2025 Revised Guidance - Seeking Alpha
- 2 months ago - Undercovered Dozen: USA Rare Earth, Santacruz Silver, Western Midstream, Visa And More - Seeking Alpha
- 2 months ago - Harrow to Present at Two Investor Conferences in December - GlobeNewsWire
- 3 months ago - Harrow Announces Closing of Acquisition of Melt Pharmaceuticals - GlobeNewsWire
- 3 months ago - Harrow, Inc. (HROW) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Harrow Announces Third Quarter 2025 Financial Results - GlobeNewsWire